Weight-loss drug semaglutide may help control asthma in people with obesity

NCT ID NCT05254314

First seen Mar 14, 2026 · Last updated Apr 28, 2026 · Updated 5 times

Summary

This study tests whether semaglutide, a drug already approved for diabetes and weight loss, can improve asthma control in adults with obesity who still have symptoms despite using inhaled steroids. About 100 participants will receive either semaglutide or a placebo for up to 24 weeks. Researchers will measure changes in asthma symptoms and markers of airway inflammation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Vanderbilt University Medical Center

    RECRUITING

    Nashville, Tennessee, 37203, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.